Disagreeing with two of his colleagues in the Eastern District of Pennsylvania, a federal judge has ruled that GlaxoSmithKline is based in Delaware, which means that drug products liability litigation against the company will remain in federal court.
April 02, 2012 at 12:00 AM
1 minute read
Disagreeing with two of his colleagues in the Eastern District of Pennsylvania, a federal judge has ruled that GlaxoSmithKline is based in Delaware, which means that drug products liability litigation against the company will remain in federal court.
The company’s decisions are made in its Wilmington, Del., office, making that place of business its “nerve center,” according to U.S. District Judge Paul Diamond of the Eastern District of Pennsylvania.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
